Cabaletta Bio

-$0.14 (-1.96%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cabaletta Bio and other ETFs, options, and stocks.

About CABA

Cabaletta Bio, Inc. operates as a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies.

CEO
Steven Nichtberger
Employees
34
Headquarters
Philadelphia, Pennsylvania
Founded
2017

CABA Key Statistics

Market Cap
155.67M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
51.92K
High Today
$7.39
Low Today
$7.00
Open Price
$7.04
Volume
44.74K
52 Week High
$16.38
52 Week Low
$7.00

CABA Earnings

-$0.65
-$0.43
-$0.22
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 17, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure